Published in Int J Nanomedicine on May 11, 2015
Evaluation of nano spray drying as a method for drying and formulation of therapeutic peptides and proteins. Front Pharmacol (2015) 0.75
Multifunctional Composite Microcapsules for Oral Delivery of Insulin. Int J Mol Sci (2016) 0.75
Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier. Int J Nanomedicine (2017) 0.75
Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev (2004) 2.10
Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes (1996) 1.31
Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int J Pharm (2002) 1.21
Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Control Release (2006) 1.15
Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection. Biomaterials (2010) 1.10
Oral insulin: the rationale for this approach and current developments. J Diabetes Sci Technol (2009) 1.10
New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes (1988) 1.07
Hydrophobic ion pairing: altering the solubility properties of biomolecules. Pharm Res (1998) 1.06
Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery. J Pharm Sci (2007) 1.03
Polymeric hydrogels for oral insulin delivery. J Control Release (2012) 1.02
The metabolic and mitogenic effects of both insulin and insulin-like growth factor are enhanced by transfection of insulin receptors into NIH3T3 fibroblasts. J Biol Chem (1989) 0.97
Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation. J Microencapsul (2010) 0.95
Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery. Adv Drug Deliv Rev (2012) 0.94
Oral colon delivery of insulin with the aid of functional adjuvants. Adv Drug Deliv Rev (2011) 0.92
Oral insulin delivery by means of solid lipid nanoparticles. Int J Nanomedicine (2007) 0.91
Intestinal absorption of peptides through the enterocytes. Microsc Res Tech (2000) 0.90
pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs. Eur J Pharm Biopharm (2012) 0.89
Targeted delivery of chitosan nanoparticles to Peyer's patch using M cell-homing peptide selected by phage display technique. Biomaterials (2010) 0.89
The physiological rationale for oral insulin administration. Diabetes Technol Ther (2004) 0.88
Applications of the ion-pair concept to hydrophilic substances with special emphasis on peptides. Pharm Res (1997) 0.88
Hydrophobic ion pairing of an insulin-sodium deoxycholate complex for oral delivery of insulin. Int J Nanomedicine (2011) 0.87
Nanolayer encapsulation of insulin-chitosan complexes improves efficiency of oral insulin delivery. Int J Nanomedicine (2014) 0.86
Feasibility, stability and release performance of a time-dependent insulin delivery system intended for oral colon release. Eur J Pharm Biopharm (2008) 0.84
Optimum formulation for sustained-release insulin. Int J Pharm (2004) 0.84
Novel non-invasive methods of insulin delivery. Expert Opin Drug Deliv (2012) 0.84
Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles. Biomaterials (2013) 0.83
In vitro degradation of insulin-loaded poly (n-butylcyanoacrylate) nanoparticles. Biomaterials (2004) 0.82
An overview of natural polymers for oral insulin delivery. Drug Discov Today (2012) 0.81
Intestinal absorption of insulin nanoparticles: contribution of M cells. Nanomedicine (2014) 0.80